Financing type:  underwritten prospectus offering

Gross proceeds:  $6,900,003.28 (U.S.)

Offering:  12,837,204 listed shares (represented by 1,069,767 American depositary shares (ADSs)) with 1,069,767 ADS warrants (Each ADS warrant is exercisable into one ADS, representing 12 listed shares.)

Offering price:  $6.45 (U.S.) per ADS

Warrant exercise terms:  12.2213 (Canadian) per ADS for a five-year period

Overallotment option:  The underwriters may purchase a maximum of 1,674,408 listed shares (represented by 139,534 ADSs) and 139,534 ADS warrants for overallotment purposes. As of April 24, 2026, such option has been fully exercised. All information presented herein includes such exercise.

Commissions in securities:  53,488 agents' warrants

Commission terms:  Each non-transferable underwriter warrant is exercisable into one ADS (representing 12 listed shares) at $9.8088 (Canadian) per ADS.

Disclosure:  Refer to the short form base shelf prospectus dated Jan. 29, 2026, prospectus supplement dated April 13, 2026, and the company's news releases dated April 13, 2026, April 14, 2026, and April 17, 2026.